The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

Clinical trial NCT05263986 · UNKNOWN

Trial details

NCT number: NCT05263986
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumor

Start date: 2022-05-30
Primary completion: 2023-10-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.